Published: 21st April 2014
The Christie NHS Foundation Trust has entered a partnership with SYNLAB UK to provide pathology services at the cancer specialist trust.
It is hoped that the Christie Pathology Partnership will improve service efficiency and bring financial benefits to the trust through improved procurement terms and increased third party activity.
Currently, the Christie provides a diagnostic and monitoring service for cancer patients undergoing chemotherapy, radiotherapy and surgery.
The partnership begins on 1st June when the staff, equipment and facilities of the Christie’s pathology laboratories will transfer to the joint venture.
SYNLAB UK is the UK division of SYNLAB, one of Europe’s largest private providers of pathology services.
We are absolutely delighted to have been selected to be the Christie’s pathology joint venture partner. We believe that the Christie brand and reputation combined with SYNLAB’s operational excellence will create a pathology partnership that will support the Christie’s sustainable development, maintain its independence and assist in the Christie being internationally recognised as one of the world’s leading comprehensive cancer centres.
Hugh Risebrow, managing director of SYNLAB UK
